Wiley A. Schell

6.8k citations

83 papers · 4.7k indexed · h-index 38

Impact in

Infectious Diseases top 0.2%
- Antifungal resistance and susceptibility
Small Animals top 0.5%
- Infectious Diseases and Mycology

Papers in ⓘ

Infectious Diseases 60
- Antifungal resistance and susceptibility 58
Epidemiology 47
- Fungal Infections and Studies 43
- Nail Diseases and Treatments 12
- Pneumocystis jirovecii pneumonia detection and treatment 5

Co-authors: John R. Perfect (54 shared papers)Aimee K. Zaas (5 shared papers)Leah E. Cowen (3 shared papers)William J. Steinbach (9 shared papers)Sheena D. Singh-Babak (2 shared papers)Barbara D. Alexander (9 shared papers)Jackie L. Miller (7 shared papers)Maurizio Del Poeta (3 shared papers)
Journals: Antimicrobial Agents and Chemotherapy (15 papers)Journal of Clinical Microbiology (9 papers)Medical Mycology (7 papers)Clinical Infectious Diseases (4 papers)Bioconjugate Chemistry (3 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

Wiley A. Schell

82 papers receiving 4.5k citations

Peers

Countries citing papers authored by Wiley A. Schell

Since Specialization

Citations

This map shows the geographic impact of Wiley A. Schell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wiley A. Schell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wiley A. Schell more than expected).

Fields of papers citing papers by Wiley A. Schell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wiley A. Schell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wiley A. Schell. The network helps show where Wiley A. Schell may publish in the future.

Co-authors

The 25 scholars most cited alongside Wiley A. Schell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wiley A. Schell Line = papers co-authored together Wiley A. Schell links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease Proceedings of the National Academy of Sciences ·Leah E. Cowen, Sheena D. Singh-Babak, Julia R. Köhler, Cathy Collins, Aimee K. Zaas, Wiley A. Schell, Hamza Aziz, Eleftherios Mylonakis, John R. Perfect, Luke Whitesell, Susan Lindquist	2009	327
2	Hsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin PLoS Pathogens ·Sheena D. Singh-Babak, Nicole Robbins, Aimee K. Zaas, Wiley A. Schell, John R. Perfect, Leah E. Cowen	2009	282
3	PKC Signaling Regulates Drug Resistance of the Fungal Pathogen Candida albicans via Circuitry Comprised of Mkc1, Calcineurin, and Hsp90 PLoS Pathogens ·Shantelle L. LaFayette, Cathy Collins, Aimee K. Zaas, Wiley A. Schell, Marisol Betancourt-Quiroz, A. A. Leslie Gunatilaka, John R. Perfect, Leah E. Cowen	2010	260
4	Structure-In Vitro Activity Relationships of Pentamidine Analogues and Dication-Substituted Bis-Benzimidazoles as New Antifungal Agents Antimicrobial Agents and Chemotherapy ·Maurizio Del Poeta, Wiley A. Schell, Christine C. Dykstra, Susan Jones, Richard R. Tidwell, Agnieszka Czarny, Miroslav Bajić, Marina Bajic, Arvind Kumar, David W. Boykin, John R. Perfect	1998	207
5	Multiplexed Real-Time Polymerase Chain Reaction on a Digital Microfluidic Platform Analytical Chemistry ·Zhishan Hua, Jeremy Rouse, Allen E. Eckhardt, Vijay Srinivasan, Vamsee K. Pamula, Wiley A. Schell, Jonathan L. Benton, Thomas G. Mitchell, Michael Pollack	2010	198
6	The New Fungal Opportunists Are Coming Clinical Infectious Diseases ·John R. Perfect, Wiley A. Schell	1996	179
7	Calcineurin Is Essential for Candida albicans Survival in Serum and Virulence Eukaryotic Cell ·Jill R. Blankenship, Floyd L. Wormley, Molly Boyce, Wiley A. Schell, Scott G. Filler, John R. Perfect, Joseph Heitman	2003	154
8	Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1 Antimicrobial Agents and Chemotherapy ·Miriam L. Cameron, Wiley A. Schell, Steve Bruch, John Bartlett, Hetty Waskin, John R. Perfect	1993	140
9	Diguanidino and “Reversed” Diamidino 2,5-Diarylfurans as Antimicrobial Agents Journal of Medicinal Chemistry ·Chad E. Stephens, Farial A. Tanious, Hanna Kim, W. David Wilson, Wiley A. Schell, John R. Perfect, Scott G. Franzblau, David W. Boykin	2001	136
10	In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds Antimicrobial Agents and Chemotherapy ·Maurizio Del Poeta, Wiley A. Schell, John R. Perfect	1997	127
11	Morphologic Criteria for the Preliminary Identification ofFusarium, Paecilomyces, andAcremoniumSpecies by Histopathology American Journal of Clinical Pathology ·Katharine Liu, D N Howell, John R. Perfect, Wiley A. Schell	1998	125
12	In Vitro Interactions between Antifungals and Immunosuppressants against Aspergillus fumigatus Antimicrobial Agents and Chemotherapy ·William J. Steinbach, Wiley A. Schell, Jill R. Blankenship, Chiatogu Onyewu, Joseph Heitman, John R. Perfect	2004	110
13	In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans Antimicrobial Agents and Chemotherapy ·John R. Perfect, G. M. Cox, R K Dodge, Wiley A. Schell	1996	108
14	Gpr1, a Putative G-Protein-Coupled Receptor, Regulates Morphogenesis and Hypha Formation in the Pathogenic Fungus Candida albicans Eukaryotic Cell ·Takuya Miwa, Yukinobu Takagi, Makiko Shinozaki, Cheol‐Won Yun, Wiley A. Schell, John R. Perfect, Hidehiko Kumagai, Hisanori Tamaki	2004	102
15	Risk of Fungemia Due to Rhodotorula and Antifungal Susceptibility Testing of Rhodotorula Isolates Journal of Clinical Microbiology ·Aimee K. Zaas, Molly Boyce, Wiley A. Schell, Barbara D. Alexander, Jackie L. Miller, John R. Perfect	2003	99
16	Quantitation of Candida CFU in Initial Positive Blood Cultures Journal of Clinical Microbiology ·Christopher D. Pfeiffer, Gregory P. Samsa, Wiley A. Schell, L. Barth Reller, John R. Perfect, Barbara D. Alexander	2011	98
17	In Vitro and In Vivo Evaluation of APX001A/APX001 and Other Gwt1 Inhibitors against Cryptococcus Antimicrobial Agents and Chemotherapy ·Karen Joy Shaw, Wiley A. Schell, Jonathan A. Covel, Gisele Duboc, Charles Giamberardino, Mili Kapoor, Molly Moloney, Quinlyn A. Soltow, Jennifer L. Tenor, Dena L. Toffaletti, Michael Trzoss, Peter J. Webb, John R. Perfect	2018	81
18	Quality Control and Reference Guidelines for CLSI Broth Microdilution Susceptibility Method (M38-A Document) for Amphotericin B, Itraconazole, Posaconazole, and Voriconazole Journal of Clinical Microbiology ·Ana Espinel‐Ingroff, A. Fothergill, Mahmoud A. Ghannoum, Elias K. Manavathu, Luis Ostrosky‐Zeichner, Michael A. Pfaller, Michael G. Rinaldi, Wiley A. Schell, Thomas J. Walsh	2005	80
19	In Vitro Antifungal Activities of a Series of Dication-Substituted Carbazoles, Furans, and Benzimidazoles Antimicrobial Agents and Chemotherapy ·Maurizio Del Poeta, Wiley A. Schell, Christine C. Dykstra, Susan Jones, Richard R. Tidwell, Arvind Kumar, David W. Boykin, John R. Perfect	1998	79
20	Fusarium Infection in Burned Patients American Journal of Clinical Pathology ·Michael S. Wheeler, Michael R. McGinnis, Wiley A. Schell, David H. Walker	1981	76

About Wiley A. Schell

Wiley A. Schell is a scholar working on Infectious Diseases, Epidemiology, Small Animals, Cell Biology and Molecular Biology, having authored 83 papers that have together received 4.7k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (58 papers), Fungal Infections and Studies (43 papers), Infectious Diseases and Mycology (17 papers), Plant Pathogens and Fungal Diseases (15 papers), Nail Diseases and Treatments (12 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers), Fungal Biology and Applications (5 papers) and Peptidase Inhibition and Analysis (4 papers). The work is most often cited by research in Infectious Diseases (2.9k citations), Small Animals (484 citations), Epidemiology (2.3k citations), Cell Biology (605 citations) and Microbiology (163 citations). Wiley A. Schell has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include John R. Perfect, Aimee K. Zaas, Leah E. Cowen, William J. Steinbach, Sheena D. Singh-Babak, Barbara D. Alexander, Jackie L. Miller, Maurizio Del Poeta, Cathy Collins and Joseph Heitman. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Clinical Microbiology, Medical Mycology, Clinical Infectious Diseases and Bioconjugate Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact